Sildodime M 50 tablet is a combination of a β3-adrenoceptor agonist (Mirabegron) and an alpha-1 blocker (Silodosin) used for managing overactive bladder and lower urinary tract symptoms associated with BPH.
It works by relaxing bladder and prostate smooth muscles, improving urinary flow, reducing urgency, frequency, and nocturia, and providing better bladder control.
This tablet is widely prescribed in overactive bladder syndrome, benign prostatic hyperplasia, and urinary retention management, helping adult patients achieve improved urinary comfort and daily convenience.
With strong clinical relevance in urology care, growing acceptance among healthcare professionals, and rising demand in bladder and BPH management, this formulation strengthens institutional and outpatient therapy portfolios and supports sustained therapeutic utilization.